CG0009
CG0009 is a potent, selective GSK3 inhibitor that suppresses proliferation and triggers apoptosis in breast cancer cells via cyclin D1 depletion and p53-Bax pathway activation. This mechanism supports its investigation as a potential therapeutic strategy, particularly in hormone therapy-resistant breast cancer models, in both in vitro and in vivo research settings.
Product Specifications
CAS Number
944744-57-4
Smiles
C (NC=1C (C) =CC=NC1) (=O) C2=C3C (N=C (N3) C4=CC=C (N (CCN (CC) CC) C) C=C4) =NC=C2
Molecular Formula
C26H31N7O
Molecular Weight
457.57
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
134178-ML405 100 µL
TAF13 (Transcription Initiation Factor TFIID Subunit 13, Transcription Initiation Factor TFIID 18kD Subunit, TAF (II) 18, TAFII-18, TAFII18, TAF2K, TAFII18, MGC22425) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
20154116 3x 1.0 µg
Fam86a sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Sign In for Pricing
View Details LV715148 1.0 µg DNA
SLC35A5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
Sign In for Pricing
View Details 